Workflow
蔚蓝生物(603739) - 2024 Q3 - 季度财报
603739Vland Biotech(603739)2024-10-28 10:02

Financial Performance - The company's operating revenue for Q3 2024 was ¥336,385,727.60, representing a year-over-year increase of 0.20%[2] - The net profit attributable to shareholders for Q3 2024 was ¥11,495,213.95, a decrease of 51.81% compared to the same period last year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,915,510.45, down 55.23% year-over-year[2] - The basic earnings per share for Q3 2024 was ¥0.05, a decrease of 44.44% year-over-year[2] - Net profit for the first three quarters of 2024 was ¥61,067,866.90, a decrease of 9.83% from ¥67,167,455.20 in the same period of 2023[12] - The net profit attributable to shareholders of the parent company for the first three quarters of 2024 was ¥40,847,212.04, down 26.24% from ¥55,323,058.81 in 2023[12] - The company’s total comprehensive income for the first three quarters of 2024 was ¥61,009,443.78, compared to ¥67,282,409.12 in 2023[12] Cash Flow - The net cash flow from operating activities for Q3 2024 was ¥10,999,893.18, a decline of 55.31% compared to the previous year[5] - Cash flow from operating activities for the first three quarters of 2024 was ¥1,022,427,892.26, an increase from ¥981,224,016.17 in 2023[12] - The net cash flow from operating activities for Q3 2024 was ¥63,201,814.62, an increase of 40% compared to ¥45,221,572.21 in Q3 2023[13] - The company reported a total cash outflow from operating activities of ¥959,226,077.64, an increase of 2.5% from ¥936,002,443.96 in Q3 2023[13] - The net cash flow from financing activities was ¥14,838,094.73, a decrease of 92% compared to ¥183,139,915.86 in Q3 2023[13] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,025,588,143.49, a decrease of 0.28% from the end of the previous year[3] - As of September 30, 2024, total current assets amounted to CNY 1,118,852,765.17, a slight decrease from CNY 1,123,941,191.15 at the end of 2023, representing a decline of approximately 0.3%[9] - The company's total assets stood at CNY 3,025,588,143.49, slightly down from CNY 3,034,057,625.33, representing a decrease of about 0.3%[9] - Total liabilities decreased to CNY 1,168,552,308.82 from CNY 1,208,671,719.25, a reduction of approximately 3.3%[10] - The total equity attributable to shareholders at the end of the reporting period was ¥1,727,583,290.07, an increase of 1.13% from the previous year[3] Expenses - The company reported a significant increase in depreciation expenses, which was a primary reason for the decline in net profit[5] - Total operating costs for the first three quarters of 2024 were ¥881,905,556.31, up 7.52% from ¥820,194,683.19 in 2023[11] - The company reported a financial expense of ¥16,144,425.99 for the first three quarters of 2024, significantly higher than ¥8,285,986.42 in 2023[11] - Research and development expenses for the first three quarters of 2024 were ¥81,303,889.41, slightly up from ¥81,196,580.70 in 2023[11] Government Support - The company received government subsidies amounting to ¥4,937,235.02 during the reporting period, contributing to its non-recurring gains[4] Current Assets - Cash and cash equivalents increased to CNY 261,677,056.56 from CNY 239,595,497.76, marking an increase of about 9.2%[7] - Accounts receivable rose to CNY 354,287,142.80, up from CNY 322,736,859.76, reflecting a growth of approximately 9.8%[9] - Inventory decreased to CNY 182,187,107.23 from CNY 205,405,397.66, indicating a decline of about 11.3%[9] - Long-term equity investments increased to CNY 85,862,219.27 from CNY 71,914,167.04, showing a growth of approximately 19.4%[9] - The company's retained earnings rose to CNY 719,963,748.80 from CNY 703,477,285.27, an increase of about 2.3%[10] - Short-term borrowings increased to CNY 612,220,000.00 from CNY 568,971,407.04, reflecting an increase of approximately 7.6%[9] - The company reported a decrease in employee compensation payable to CNY 18,091,307.26 from CNY 38,357,423.62, a decline of about 52.9%[10] Investment Activities - Total cash outflow from investment activities was ¥684,590,067.62, down 15% from ¥804,224,932.87 in the same period last year[13] - Cash paid for purchasing fixed assets and intangible assets was ¥62,956,067.62, a decrease of 34% compared to ¥95,858,900.59 in the same period last year[13] - The company received cash from investment income of ¥15,236,443.23, which is an increase of 75% from ¥8,698,329.13 in Q3 2023[13] Financing Activities - The total cash inflow from financing activities was ¥573,362,488.53, an increase of 12% from ¥511,519,738.30 in Q3 2023[13] - The company paid ¥457,350,000.00 in cash for debt repayment, which is an increase of 62% compared to ¥281,700,000.00 in Q3 2023[13] - The cash outflow for other financing activities was ¥43,698,482.20, with no previous year comparison available[13]